0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Invasive Glucose Monitoring Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-3H7751
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
China Non Invasive Glucose Monitoring Market Report Forecast 2021 2027
BUY CHAPTERS

Global Non-Invasive Glucose Monitoring Market Research Report 2025

Code: QYRE-Auto-3H7751
Report
August 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Non-Invasive Glucose Monitoring Market Size

The global market for Non-Invasive Glucose Monitoring was valued at US$ 5448 million in the year 2024 and is projected to reach a revised size of US$ 6816 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Non-Invasive Glucose Monitoring Market

Non-Invasive Glucose Monitoring Market

Non-invasive glucose monitoring refers to blood glucose measurement methods that do not require the collection of a blood sample. These methods include technologies such as optical sensors, spectroscopy, and transdermal glucose monitoring.
The market for non-invasive glucose monitoring is driven by the growing demand for painless and convenient glucose monitoring solutions, especially among individuals with diabetes who require frequent blood glucose testing. Technological advancements in non-invasive glucose monitoring devices, such as wearable sensors and mobile health applications, have also impacted the market"s growth.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Non-Invasive Glucose Monitoring, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Invasive Glucose Monitoring.
The Non-Invasive Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Invasive Glucose Monitoring market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Invasive Glucose Monitoring manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Non-Invasive Glucose Monitoring Market Report

Report Metric Details
Report Name Non-Invasive Glucose Monitoring Market
Accounted market size in year US$ 5448 million
Forecasted market size in 2031 US$ 6816 million
CAGR 3.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices, Nova Biomedical, Bionime Corporation, Sinocare, Hybio Pharmaceutical, Lepu Medical, Yuyue Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Non-Invasive Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Non-Invasive Glucose Monitoring in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Non-Invasive Glucose Monitoring Market growing?

Ans: The Non-Invasive Glucose Monitoring Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Non-Invasive Glucose Monitoring Market size in 2031?

Ans: The Non-Invasive Glucose Monitoring Market size in 2031 will be US$ 6816 million.

Who are the main players in the Non-Invasive Glucose Monitoring Market report?

Ans: The main players in the Non-Invasive Glucose Monitoring Market are Abbott, Medtronic, Roche, Bayer AG, B. Braun, Nipro Diagnostics, Life Scan Inc.(J&J), Arkray Devices, Nova Biomedical, Bionime Corporation, Sinocare, Hybio Pharmaceutical, Lepu Medical, Yuyue Medical

What are the Application segmentation covered in the Non-Invasive Glucose Monitoring Market report?

Ans: The Applications covered in the Non-Invasive Glucose Monitoring Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Non-Invasive Glucose Monitoring Market report?

Ans: The Types covered in the Non-Invasive Glucose Monitoring Market report are Wearable Blood Glucose Monitoring Systems, Table Top Blood Glucose Monitoring Systems

Recommended Reports

Non-Invasive Glucose

Continuous Glucose Monitoring

Glucose Meter Devices

1 Non-Invasive Glucose Monitoring Market Overview
1.1 Product Definition
1.2 Non-Invasive Glucose Monitoring by Type
1.2.1 Global Non-Invasive Glucose Monitoring Market Value Comparison by Type (2024 VS 2031)
1.2.2 Wearable Blood Glucose Monitoring Systems
1.2.3 Table Top Blood Glucose Monitoring Systems
1.3 Non-Invasive Glucose Monitoring by Application
1.3.1 Global Non-Invasive Glucose Monitoring Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Non-Invasive Glucose Monitoring Market Size Estimates and Forecasts
1.4.1 Global Non-Invasive Glucose Monitoring Revenue 2020-2031
1.4.2 Global Non-Invasive Glucose Monitoring Sales 2020-2031
1.4.3 Global Non-Invasive Glucose Monitoring Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Non-Invasive Glucose Monitoring Market Competition by Manufacturers
2.1 Global Non-Invasive Glucose Monitoring Sales Market Share by Manufacturers (2020-2025)
2.2 Global Non-Invasive Glucose Monitoring Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Non-Invasive Glucose Monitoring Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Non-Invasive Glucose Monitoring, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-Invasive Glucose Monitoring, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-Invasive Glucose Monitoring, Product Type & Application
2.7 Global Key Manufacturers of Non-Invasive Glucose Monitoring, Date of Enter into This Industry
2.8 Global Non-Invasive Glucose Monitoring Market Competitive Situation and Trends
2.8.1 Global Non-Invasive Glucose Monitoring Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Non-Invasive Glucose Monitoring Players Market Share by Revenue
2.8.3 Global Non-Invasive Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Non-Invasive Glucose Monitoring Market Scenario by Region
3.1 Global Non-Invasive Glucose Monitoring Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Non-Invasive Glucose Monitoring Sales by Region: 2020-2031
3.2.1 Global Non-Invasive Glucose Monitoring Sales by Region: 2020-2025
3.2.2 Global Non-Invasive Glucose Monitoring Sales by Region: 2026-2031
3.3 Global Non-Invasive Glucose Monitoring Revenue by Region: 2020-2031
3.3.1 Global Non-Invasive Glucose Monitoring Revenue by Region: 2020-2025
3.3.2 Global Non-Invasive Glucose Monitoring Revenue by Region: 2026-2031
3.4 North America Non-Invasive Glucose Monitoring Market Facts & Figures by Country
3.4.1 North America Non-Invasive Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Non-Invasive Glucose Monitoring Sales by Country (2020-2031)
3.4.3 North America Non-Invasive Glucose Monitoring Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Non-Invasive Glucose Monitoring Market Facts & Figures by Country
3.5.1 Europe Non-Invasive Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Non-Invasive Glucose Monitoring Sales by Country (2020-2031)
3.5.3 Europe Non-Invasive Glucose Monitoring Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-Invasive Glucose Monitoring Market Facts & Figures by Region
3.6.1 Asia Pacific Non-Invasive Glucose Monitoring Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Non-Invasive Glucose Monitoring Sales by Region (2020-2031)
3.6.3 Asia Pacific Non-Invasive Glucose Monitoring Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Non-Invasive Glucose Monitoring Market Facts & Figures by Country
3.7.1 Latin America Non-Invasive Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Non-Invasive Glucose Monitoring Sales by Country (2020-2031)
3.7.3 Latin America Non-Invasive Glucose Monitoring Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-Invasive Glucose Monitoring Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-Invasive Glucose Monitoring Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Non-Invasive Glucose Monitoring Sales by Country (2020-2031)
3.8.3 Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Non-Invasive Glucose Monitoring Sales by Type (2020-2031)
4.1.1 Global Non-Invasive Glucose Monitoring Sales by Type (2020-2025)
4.1.2 Global Non-Invasive Glucose Monitoring Sales by Type (2026-2031)
4.1.3 Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2020-2031)
4.2 Global Non-Invasive Glucose Monitoring Revenue by Type (2020-2031)
4.2.1 Global Non-Invasive Glucose Monitoring Revenue by Type (2020-2025)
4.2.2 Global Non-Invasive Glucose Monitoring Revenue by Type (2026-2031)
4.2.3 Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2020-2031)
4.3 Global Non-Invasive Glucose Monitoring Price by Type (2020-2031)
5 Segment by Application
5.1 Global Non-Invasive Glucose Monitoring Sales by Application (2020-2031)
5.1.1 Global Non-Invasive Glucose Monitoring Sales by Application (2020-2025)
5.1.2 Global Non-Invasive Glucose Monitoring Sales by Application (2026-2031)
5.1.3 Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2020-2031)
5.2 Global Non-Invasive Glucose Monitoring Revenue by Application (2020-2031)
5.2.1 Global Non-Invasive Glucose Monitoring Revenue by Application (2020-2025)
5.2.2 Global Non-Invasive Glucose Monitoring Revenue by Application (2026-2031)
5.2.3 Global Non-Invasive Glucose Monitoring Revenue Market Share by Application (2020-2031)
5.3 Global Non-Invasive Glucose Monitoring Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Abbott Non-Invasive Glucose Monitoring Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Non-Invasive Glucose Monitoring Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Roche
6.3.1 Roche Company Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Roche Non-Invasive Glucose Monitoring Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Bayer AG
6.4.1 Bayer AG Company Information
6.4.2 Bayer AG Description and Business Overview
6.4.3 Bayer AG Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Bayer AG Non-Invasive Glucose Monitoring Product Portfolio
6.4.5 Bayer AG Recent Developments/Updates
6.5 B. Braun
6.5.1 B. Braun Company Information
6.5.2 B. Braun Description and Business Overview
6.5.3 B. Braun Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.5.4 B. Braun Non-Invasive Glucose Monitoring Product Portfolio
6.5.5 B. Braun Recent Developments/Updates
6.6 Nipro Diagnostics
6.6.1 Nipro Diagnostics Company Information
6.6.2 Nipro Diagnostics Description and Business Overview
6.6.3 Nipro Diagnostics Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Nipro Diagnostics Non-Invasive Glucose Monitoring Product Portfolio
6.6.5 Nipro Diagnostics Recent Developments/Updates
6.7 Life Scan Inc.(J&J)
6.7.1 Life Scan Inc.(J&J) Company Information
6.7.2 Life Scan Inc.(J&J) Description and Business Overview
6.7.3 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product Portfolio
6.7.5 Life Scan Inc.(J&J) Recent Developments/Updates
6.8 Arkray Devices
6.8.1 Arkray Devices Company Information
6.8.2 Arkray Devices Description and Business Overview
6.8.3 Arkray Devices Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Arkray Devices Non-Invasive Glucose Monitoring Product Portfolio
6.8.5 Arkray Devices Recent Developments/Updates
6.9 Nova Biomedical
6.9.1 Nova Biomedical Company Information
6.9.2 Nova Biomedical Description and Business Overview
6.9.3 Nova Biomedical Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Nova Biomedical Non-Invasive Glucose Monitoring Product Portfolio
6.9.5 Nova Biomedical Recent Developments/Updates
6.10 Bionime Corporation
6.10.1 Bionime Corporation Company Information
6.10.2 Bionime Corporation Description and Business Overview
6.10.3 Bionime Corporation Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Bionime Corporation Non-Invasive Glucose Monitoring Product Portfolio
6.10.5 Bionime Corporation Recent Developments/Updates
6.11 Sinocare
6.11.1 Sinocare Company Information
6.11.2 Sinocare Description and Business Overview
6.11.3 Sinocare Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sinocare Non-Invasive Glucose Monitoring Product Portfolio
6.11.5 Sinocare Recent Developments/Updates
6.12 Hybio Pharmaceutical
6.12.1 Hybio Pharmaceutical Company Information
6.12.2 Hybio Pharmaceutical Description and Business Overview
6.12.3 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product Portfolio
6.12.5 Hybio Pharmaceutical Recent Developments/Updates
6.13 Lepu Medical
6.13.1 Lepu Medical Company Information
6.13.2 Lepu Medical Description and Business Overview
6.13.3 Lepu Medical Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Lepu Medical Non-Invasive Glucose Monitoring Product Portfolio
6.13.5 Lepu Medical Recent Developments/Updates
6.14 Yuyue Medical
6.14.1 Yuyue Medical Company Information
6.14.2 Yuyue Medical Description and Business Overview
6.14.3 Yuyue Medical Non-Invasive Glucose Monitoring Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Yuyue Medical Non-Invasive Glucose Monitoring Product Portfolio
6.14.5 Yuyue Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-Invasive Glucose Monitoring Industry Chain Analysis
7.2 Non-Invasive Glucose Monitoring Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-Invasive Glucose Monitoring Production Mode & Process Analysis
7.4 Non-Invasive Glucose Monitoring Sales and Marketing
7.4.1 Non-Invasive Glucose Monitoring Sales Channels
7.4.2 Non-Invasive Glucose Monitoring Distributors
7.5 Non-Invasive Glucose Monitoring Customer Analysis
8 Non-Invasive Glucose Monitoring Market Dynamics
8.1 Non-Invasive Glucose Monitoring Industry Trends
8.2 Non-Invasive Glucose Monitoring Market Drivers
8.3 Non-Invasive Glucose Monitoring Market Challenges
8.4 Non-Invasive Glucose Monitoring Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Non-Invasive Glucose Monitoring Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Non-Invasive Glucose Monitoring Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Non-Invasive Glucose Monitoring Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Non-Invasive Glucose Monitoring Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Non-Invasive Glucose Monitoring Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Non-Invasive Glucose Monitoring Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Non-Invasive Glucose Monitoring Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Non-Invasive Glucose Monitoring Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Non-Invasive Glucose Monitoring, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Non-Invasive Glucose Monitoring, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Non-Invasive Glucose Monitoring, Product Type & Application
 Table 12. Global Key Manufacturers of Non-Invasive Glucose Monitoring, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Non-Invasive Glucose Monitoring by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Invasive Glucose Monitoring as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Non-Invasive Glucose Monitoring Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Non-Invasive Glucose Monitoring Sales by Region (2020-2025) & (K Units)
 Table 18. Global Non-Invasive Glucose Monitoring Sales Market Share by Region (2020-2025)
 Table 19. Global Non-Invasive Glucose Monitoring Sales by Region (2026-2031) & (K Units)
 Table 20. Global Non-Invasive Glucose Monitoring Sales Market Share by Region (2026-2031)
 Table 21. Global Non-Invasive Glucose Monitoring Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Non-Invasive Glucose Monitoring Revenue Market Share by Region (2020-2025)
 Table 23. Global Non-Invasive Glucose Monitoring Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Non-Invasive Glucose Monitoring Revenue Market Share by Region (2026-2031)
 Table 25. North America Non-Invasive Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Non-Invasive Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 27. North America Non-Invasive Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 28. North America Non-Invasive Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Non-Invasive Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Non-Invasive Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Non-Invasive Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Non-Invasive Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Non-Invasive Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Non-Invasive Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Non-Invasive Glucose Monitoring Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Non-Invasive Glucose Monitoring Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Non-Invasive Glucose Monitoring Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Non-Invasive Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Non-Invasive Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Non-Invasive Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Non-Invasive Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Non-Invasive Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Non-Invasive Glucose Monitoring Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Non-Invasive Glucose Monitoring Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Non-Invasive Glucose Monitoring Sales (K Units) by Type (2020-2025)
 Table 51. Global Non-Invasive Glucose Monitoring Sales (K Units) by Type (2026-2031)
 Table 52. Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2020-2025)
 Table 53. Global Non-Invasive Glucose Monitoring Sales Market Share by Type (2026-2031)
 Table 54. Global Non-Invasive Glucose Monitoring Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Non-Invasive Glucose Monitoring Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2020-2025)
 Table 57. Global Non-Invasive Glucose Monitoring Revenue Market Share by Type (2026-2031)
 Table 58. Global Non-Invasive Glucose Monitoring Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Non-Invasive Glucose Monitoring Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Non-Invasive Glucose Monitoring Sales (K Units) by Application (2020-2025)
 Table 61. Global Non-Invasive Glucose Monitoring Sales (K Units) by Application (2026-2031)
 Table 62. Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2020-2025)
 Table 63. Global Non-Invasive Glucose Monitoring Sales Market Share by Application (2026-2031)
 Table 64. Global Non-Invasive Glucose Monitoring Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Non-Invasive Glucose Monitoring Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Non-Invasive Glucose Monitoring Revenue Market Share by Application (2020-2025)
 Table 67. Global Non-Invasive Glucose Monitoring Revenue Market Share by Application (2026-2031)
 Table 68. Global Non-Invasive Glucose Monitoring Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Non-Invasive Glucose Monitoring Price (US$/Unit) by Application (2026-2031)
 Table 70. Abbott Company Information
 Table 71. Abbott Description and Business Overview
 Table 72. Abbott Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Abbott Non-Invasive Glucose Monitoring Product
 Table 74. Abbott Recent Developments/Updates
 Table 75. Medtronic Company Information
 Table 76. Medtronic Description and Business Overview
 Table 77. Medtronic Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Medtronic Non-Invasive Glucose Monitoring Product
 Table 79. Medtronic Recent Developments/Updates
 Table 80. Roche Company Information
 Table 81. Roche Description and Business Overview
 Table 82. Roche Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Roche Non-Invasive Glucose Monitoring Product
 Table 84. Roche Recent Developments/Updates
 Table 85. Bayer AG Company Information
 Table 86. Bayer AG Description and Business Overview
 Table 87. Bayer AG Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Bayer AG Non-Invasive Glucose Monitoring Product
 Table 89. Bayer AG Recent Developments/Updates
 Table 90. B. Braun Company Information
 Table 91. B. Braun Description and Business Overview
 Table 92. B. Braun Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. B. Braun Non-Invasive Glucose Monitoring Product
 Table 94. B. Braun Recent Developments/Updates
 Table 95. Nipro Diagnostics Company Information
 Table 96. Nipro Diagnostics Description and Business Overview
 Table 97. Nipro Diagnostics Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Nipro Diagnostics Non-Invasive Glucose Monitoring Product
 Table 99. Nipro Diagnostics Recent Developments/Updates
 Table 100. Life Scan Inc.(J&J) Company Information
 Table 101. Life Scan Inc.(J&J) Description and Business Overview
 Table 102. Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Life Scan Inc.(J&J) Non-Invasive Glucose Monitoring Product
 Table 104. Life Scan Inc.(J&J) Recent Developments/Updates
 Table 105. Arkray Devices Company Information
 Table 106. Arkray Devices Description and Business Overview
 Table 107. Arkray Devices Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Arkray Devices Non-Invasive Glucose Monitoring Product
 Table 109. Arkray Devices Recent Developments/Updates
 Table 110. Nova Biomedical Company Information
 Table 111. Nova Biomedical Description and Business Overview
 Table 112. Nova Biomedical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Nova Biomedical Non-Invasive Glucose Monitoring Product
 Table 114. Nova Biomedical Recent Developments/Updates
 Table 115. Bionime Corporation Company Information
 Table 116. Bionime Corporation Description and Business Overview
 Table 117. Bionime Corporation Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Bionime Corporation Non-Invasive Glucose Monitoring Product
 Table 119. Bionime Corporation Recent Developments/Updates
 Table 120. Sinocare Company Information
 Table 121. Sinocare Description and Business Overview
 Table 122. Sinocare Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sinocare Non-Invasive Glucose Monitoring Product
 Table 124. Sinocare Recent Developments/Updates
 Table 125. Hybio Pharmaceutical Company Information
 Table 126. Hybio Pharmaceutical Description and Business Overview
 Table 127. Hybio Pharmaceutical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Hybio Pharmaceutical Non-Invasive Glucose Monitoring Product
 Table 129. Hybio Pharmaceutical Recent Developments/Updates
 Table 130. Lepu Medical Company Information
 Table 131. Lepu Medical Description and Business Overview
 Table 132. Lepu Medical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Lepu Medical Non-Invasive Glucose Monitoring Product
 Table 134. Lepu Medical Recent Developments/Updates
 Table 135. Yuyue Medical Company Information
 Table 136. Yuyue Medical Description and Business Overview
 Table 137. Yuyue Medical Non-Invasive Glucose Monitoring Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Yuyue Medical Non-Invasive Glucose Monitoring Product
 Table 139. Yuyue Medical Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Non-Invasive Glucose Monitoring Distributors List
 Table 143. Non-Invasive Glucose Monitoring Customers List
 Table 144. Non-Invasive Glucose Monitoring Market Trends
 Table 145. Non-Invasive Glucose Monitoring Market Drivers
 Table 146. Non-Invasive Glucose Monitoring Market Challenges
 Table 147. Non-Invasive Glucose Monitoring Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Non-Invasive Glucose Monitoring
 Figure 2. Global Non-Invasive Glucose Monitoring Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-Invasive Glucose Monitoring Market Share by Type: 2024 & 2031
 Figure 4. Wearable Blood Glucose Monitoring Systems Product Picture
 Figure 5. Table Top Blood Glucose Monitoring Systems Product Picture
 Figure 6. Global Non-Invasive Glucose Monitoring Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Non-Invasive Glucose Monitoring Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Non-Invasive Glucose Monitoring Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Non-Invasive Glucose Monitoring Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Non-Invasive Glucose Monitoring Sales (2020-2031) & (K Units)
 Figure 14. Global Non-Invasive Glucose Monitoring Average Price (US$/Unit) & (2020-2031)
 Figure 15. Non-Invasive Glucose Monitoring Report Years Considered
 Figure 16. Non-Invasive Glucose Monitoring Sales Share by Manufacturers in 2024
 Figure 17. Global Non-Invasive Glucose Monitoring Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Non-Invasive Glucose Monitoring Players: Market Share by Revenue in Non-Invasive Glucose Monitoring in 2024
 Figure 19. Non-Invasive Glucose Monitoring Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Non-Invasive Glucose Monitoring Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Non-Invasive Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 22. North America Non-Invasive Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 23. United States Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Non-Invasive Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 26. Europe Non-Invasive Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Non-Invasive Glucose Monitoring Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Non-Invasive Glucose Monitoring Revenue Market Share by Region (2020-2031)
 Figure 34. China Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Non-Invasive Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Non-Invasive Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Non-Invasive Glucose Monitoring Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Non-Invasive Glucose Monitoring Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Non-Invasive Glucose Monitoring Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Non-Invasive Glucose Monitoring by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Non-Invasive Glucose Monitoring by Type (2020-2031)
 Figure 55. Global Non-Invasive Glucose Monitoring Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Non-Invasive Glucose Monitoring by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Non-Invasive Glucose Monitoring by Application (2020-2031)
 Figure 58. Global Non-Invasive Glucose Monitoring Price (US$/Unit) by Application (2020-2031)
 Figure 59. Non-Invasive Glucose Monitoring Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS